Page last updated: 2024-08-21

dihydroergotamine and Allodynia

dihydroergotamine has been researched along with Allodynia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Argüelles, CF; Godínez-Chaparro, B; Granados-Soto, V; López-Santillán, FJ; Villalón, CM	1
Diener, HC; Schürks, M	1
Bourgoin, S; Hamon, M; Kayser, V; Latrémolière, A	1
Borland, SW; Hu, B; Kori, SH; Mathew, NT; Silberstein, SD; Tepper, SJ; Wang, MH	1
Bradley, KC; Gebeline-Myers, C; Hopkins, MM; Silberstein, SD; Young, WB	1

Reviews

1 review(s) available for dihydroergotamine and Allodynia

Article	Year
Migraine, allodynia, and implications for treatment. European journal of neurology, 2008, Volume: 15, Issue:12 Topics: Analgesics; Brain; Clinical Trials as Topic; Comorbidity; Cyclooxygenase Inhibitors; Dihydroergotamine; Humans; Hyperalgesia; Migraine Disorders; Trigeminal Nerve; Tryptamines	2008

Trials

2 trial(s) available for dihydroergotamine and Allodynia

Article	Year
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia. Headache, 2012, Volume: 52, Issue:1 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperalgesia; Male; Middle Aged; Migraine Disorders; Pain Measurement; Surveys and Questionnaires; Treatment Outcome; Young Adult	2012
Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial. Headache, 2007, Volume: 47, Issue:6 Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Hyperalgesia; Injections, Intramuscular; Male; Middle Aged; Migraine Disorders; Physical Stimulation; Pilot Projects; Time Factors; Treatment Outcome	2007

Article

Year

Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.

Headache, 2012, Volume: 52, Issue:1

Topics: Administration, Inhalation; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperalgesia; Male; Middle Aged; Migraine Disorders; Pain Measurement; Surveys and Questionnaires; Treatment Outcome; Young Adult

2012

Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.

Headache, 2007, Volume: 47, Issue:6

Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Hyperalgesia; Injections, Intramuscular; Male; Middle Aged; Migraine Disorders; Physical Stimulation; Pilot Projects; Time Factors; Treatment Outcome

2007

Other Studies

2 other study(ies) available for dihydroergotamine and Allodynia

Article	Year
Role of 5-HT₁B/₁D receptors in the reduction of formalin-induced nociception and secondary allodynia/hyperalgesia produced by antimigraine drugs in rats. Life sciences, 2013, Jun-13, Volume: 92, Issue:22 Topics: Acute Pain; Animals; Biphenyl Compounds; Chronic Pain; Dihydroergotamine; Disease Models, Animal; Drug Therapy, Combination; Female; Formaldehyde; Hyperalgesia; Methysergide; Nociceptive Pain; Piperazines; Piperidones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Antagonists; Spiro Compounds; Sumatriptan	2013
N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain. European journal of pain (London, England), 2011, Volume: 15, Issue:5 Topics: Analgesics, Non-Narcotic; Animals; Cycloserine; Dihydroergotamine; Disease Models, Animal; Drug Synergism; Excitatory Amino Acid Antagonists; Hyperalgesia; Male; Motor Activity; Oxazolidinones; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sciatica; Serotonin 5-HT1 Receptor Agonists; Trigeminal Neuralgia; Tryptamines	2011

Article

Year

Role of 5-HT₁B/₁D receptors in the reduction of formalin-induced nociception and secondary allodynia/hyperalgesia produced by antimigraine drugs in rats.

Life sciences, 2013, Jun-13, Volume: 92, Issue:22

Topics: Acute Pain; Animals; Biphenyl Compounds; Chronic Pain; Dihydroergotamine; Disease Models, Animal; Drug Therapy, Combination; Female; Formaldehyde; Hyperalgesia; Methysergide; Nociceptive Pain; Piperazines; Piperidones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Antagonists; Spiro Compounds; Sumatriptan

2013

N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain.

European journal of pain (London, England), 2011, Volume: 15, Issue:5

Topics: Analgesics, Non-Narcotic; Animals; Cycloserine; Dihydroergotamine; Disease Models, Animal; Drug Synergism; Excitatory Amino Acid Antagonists; Hyperalgesia; Male; Motor Activity; Oxazolidinones; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sciatica; Serotonin 5-HT1 Receptor Agonists; Trigeminal Neuralgia; Tryptamines

2011